Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced that preclinical research findings on PTG-200, the company's oral peptide IL-23 receptor antagonist, has been accepted for oral...

Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that it has 13 presentations at the upcoming 69th American Academy of Neurology (AAN) annual meeting taking place...

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will showcase...

Cross Audience today announced the launch of its Mobile App Conquesting solution, a unique offering that allows marketers to target, engage and win customers who use competitor apps. Advertisers...

Leading virtual care company Zipnosis today announced a recent study that illustrates the true downstream revenue impact of virtual care as a patient acquisition channel for health systems. The...